Literature DB >> 2923745

Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study.

M Lönnemark1, A Hemmingsson, T Bach-Gansmo, A Ericsson, A Oksendal, R Nyman, A Moxnes.   

Abstract

Non-biodegradable superparamagnetic particles were used as an oral contrast medium in different concentrations, and evaluated in 25 human volunteers. The aim of the study was to determine the most appropriate concentration of the contrast medium, and to evaluate the effect, distribution, safety and tolerance. With the concentration of 1.0 g/l a substantial reduction of the signal intensity in the bowel was achieved in both T1 and T2 weighted images. The intraabdominal structures were well differentiated from the bowels containing contrast medium. 'Metal' artifacts and blurring of adjacent structures, probably due to an increased local concentration, were observed at higher dosages. The distribution of the preparation in the gastrointestinal tract varied between individuals. As a rule a good contrast effect was achieved in the small bowel with the exception of the duodenum. The contrast medium was well accepted and did not cause any side effects of clinical importance. The results suggest that the preparation is well tolerated by humans and may be a useful contrast medium for abdominal MR imaging.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923745

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

Review 1.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

2.  Nanoparticles of gadolinium-incorporated Prussian blue with PEG coating as an effective oral MRI contrast agent for gastrointestinal tract imaging.

Authors:  Vindya S Perera; Guojun Chen; Qing Cai; Songping D Huang
Journal:  Analyst       Date:  2016-03-21       Impact factor: 4.616

3.  Gd-DTPA as an intestinal contrast agent for MR imaging of the lower abdomen: phase III clinical trial.

Authors:  L Vlahos; A Gouliamos; W Clauss; A Kalovidouris; A Athanasopoulou; A Petroulakis; A Hadjiioannou; C Papavasiliou
Journal:  Gastrointest Radiol       Date:  1992

4.  Abdominal pseudotumors and simulated lymphadenopathy in MRI: differential features with the use of retrograde air insufflation.

Authors:  C K Chou; R S Sheu; C W Yang; M L Wang; L T Chen
Journal:  Abdom Imaging       Date:  1994 Nov-Dec

5.  Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA.

Authors:  S A Mirowitz
Journal:  Abdom Imaging       Date:  1993
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.